"When you look at the hard numbers a research project on 20 veterans is not even yawn worthy."

MDMA did not work before but let's do it anyway?

Wounded Times
Kathie Costos
January 20, 2020

My emails have been piling up the last couple of days with this type of news.

Pioneering research in its third phase of trials with the FDA evaluates the safety and effectiveness of using MDMA—called molly or ecstasy—to treat post-traumatic stress disorders.

IT IS NOT NEW NEWS and there is a reason for that. It was done, redone and doggonit done again!

The first post on Wounded Times goes back to 2007 Tom Shoder of the Washington Post wanted to hear from readers about MDMA. He followed that up a few days later with Ecstasy Trials: Was it a fluke or the future?

In 2008, there was a "new look" at it, even though the subject of the article, MAPS President Rick Doblin had been aware of it since 1982.

On the post another report that went back to 2005 from The Guardian, also took a look at it. (That link is still active as of today.)

There were more from then to 2013 when I wrote that Euphoria over PTSD drugs needs to over and pointed out past studies along with this sentiment "When you look at the hard numbers a research project on 20 veterans is not even yawn worthy."

Well, full circle up to 2018 with another slam at this sham, there was another trial and this time they had a whopping 26 combat veterans! WOW, we were supposed to be impressed?

Reporters need to use all the extra time on their hands to actually start to do some basic research and folks passing this crapload forward need to go play a game of candy crush so they stop wasting everyone else's time!

UPDATE

FDA Expands Access to Ecstasy Drug for PTSD Therapy